SOC Telemed, Inc. (TLMD) News
Filter TLMD News Items
TLMD News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest TLMD News From Around the Web
Below are the latest news stories about SOC Telemed Inc that investors may wish to consider to help them evaluate TLMD as an investment opportunity.
What Type Of Shareholders Own The Most Number of SOC Telemed, Inc. (NASDAQ:TLMD) Shares?The big shareholder groups in SOC Telemed, Inc. ( NASDAQ:TLMD ) have power over the company. Generally speaking, as a... |
SOC Telemed inks a deal to go private — just 15 months after it first went public via a SPAC dealThe telemedicine company has had a whirlwind year with multiple leadership changes and an internal restructuring with layoffs and other cuts. |
MP Stock: 15 Things to Know About the Short Report Stinging EV Play MP MaterialsMP Materials (MP) stock is taking a beating on Thursday thanks to a new short report calling out the electric vehicle (EV) play. |
SOC Telemed to be Acquired by Patient Square CapitalSOC Telemed, Inc. (NASDAQ: TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced that it has entered into a definitive agreement to be acquired by Patient Square Capital ("Patient Square"), the leading dedicated health care investment firm. |
Robert W. Baird Thinks SOC Telemed’s Stock is Going to RecoverIn a report issued on November 15, Vikram Kesavabhotla from Robert W. Baird maintained a Buy rating on SOC Telemed (TLMD – Research Report), with a price target of $4.00. The company's shares closed last Wednesday at $2.14, close to its 52-week low of $1.86. According to TipRanks.com, Kesavabhotla has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -6.7% and a 41.7% success rate. Kesavabhotla covers the Technology sector, focusing on stocks such as Definitive Healthcare Corp, Tabula Rasa HealthCare, and InnovAge Holding. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for SOC Telemed with a $5. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayGood morning, trader! |
SOC Telemed Reports Third Quarter 2021 Financial and Operating ResultsSOC Telemed, Inc., (NASDAQ: TLMD), the largest national provider of acute care telemedicine, today announced its financial and operating results for the third quarter ending September 30, 2021. |
Investors in SOC Telemed (NASDAQ:TLMD) have unfortunately lost 76% over the last yearEven the best investor on earth makes unsuccessful investments. But it should be a priority to avoid stomach churning... |
SOC Telemed to Provide Corporate and Financial Update for the Third Quarter 2021 on November 12, 2021SOC Telemed, Inc. (NASDAQ: TLMD), the largest national provider of acute care telemedicine, today announced that the company will provide a corporate and financial update for the third quarter 2021, on Friday, November 12, 2021, before market open. SOC Telemed's management team will host a conference call and live audio webcast at 8:00 a.m. ET. |
SOC Telemed and Ob Hospitalist Group Announce Nationwide PartnershipSOC Telemed (NASDAQ: TLMD), the largest national provider of acute care telemedicine, and Ob Hospitalist Group (OBHG), the nation's largest and only dedicated provider of customized obstetric (OB) hospitalist programs, today announced a collaboration combining OBHG's leading OB hospitalist programs with SOC Telemed's maternal-fetal medicine (MFM) experts. The first hospital partner to go live with the new service in early August 2021 was Hendrick Medical Center in Abilene, Texas. The combined OB |